Sanofi (SNY)
NASDAQ·Healthcare·Drug Manufacturers - General
$45.95
+0.11%
Mkt Cap $107.11B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 23, 2026 | $12.70B | — | — | $1.06 | $1.10 | +3.77% | — | — |
| Q1 2026 Jan 29, 2026 | $11.71B | $14.34B | +22.38% | $0.84 | $0.89 | +5.95% | — | — |
| Q4 2025 Oct 24, 2025 | $11.11B | $15.43B | +38.89% | $1.60 | $1.70 | +6.25% | — | — |
| Q3 2025 Jul 31, 2025 | $12.36B | $12.64B | +2.28% | $0.96 | $0.90 | -6.25% | — | — |
| Q2 2025 Apr 24, 2025 | $10.00B | $11.63B | +16.31% | $0.90 | $0.94 | +4.44% | — | — |
| Q1 2025 Jan 30, 2025 | $9.51B | $7.90B | -16.89% | $0.71 | $0.70 | -1.41% | — | — |
| Q4 2024 Oct 25, 2024 | $13.94B | $15.53B | +11.39% | $1.35 | $1.57 | +16.30% | — | — |
| Q3 2024 Jul 25, 2024 | $14.76B | $12.24B | -17.11% | $0.86 | $0.93 | +8.14% | — | — |
| Q2 2024 Apr 25, 2024 | — | $11.94B | — | $0.94 | $0.97 | +3.19% | — | — |
| Q1 2024 Feb 1, 2024 | — | $25.17B | — | $0.94 | $0.89 | -5.32% | — | — |
| Q4 2023 Oct 27, 2023 | — | $13.39B | — | $1.37 | $1.39 | +1.46% | — | — |
| Q3 2023 Jul 28, 2023 | — | $11.65B | — | $1.55 | $0.95 | -38.71% | — | — |
| Q2 2023 Apr 27, 2023 | — | $11.81B | — | $1.10 | $1.16 | +5.45% | — | — |
| Q1 2023 Feb 3, 2023 | $11.50B | $12.34B | +7.32% | $0.90 | $0.87 | -3.33% | — | — |
| Q4 2022 Oct 28, 2022 | $11.63B | $12.83B | +10.31% | $1.34 | $1.44 | +7.46% | — | — |
| Q3 2022 Jul 28, 2022 | $10.00B | $11.24B | +12.33% | $0.87 | $0.92 | +5.75% | — | — |
| Q2 2022 Apr 28, 2022 | $10.03B | $11.12B | +10.90% | $0.94 | $1.09 | +15.96% | — | — |
| Q1 2022 Feb 4, 2022 | $11.57B | $11.81B | +2.02% | $0.72 | $0.79 | +9.72% | — | — |
| Q4 2021 Oct 28, 2021 | $12.07B | $12.57B | +4.10% | $1.18 | $1.29 | +9.32% | — | — |
| Q3 2021 Jul 29, 2021 | $10.54B | $10.73B | +1.86% | $0.75 | $0.83 | +10.67% | — | — |